Computational simulations of local vascular heparin deposition and distribution

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 271, Issue 5 40-5, 1996, Pages

  Lovich, Mark A ^a   Edelman, Elazer R ^b  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b NONE

Author keywords

artery; binding; diffusion; drug delivery; model

Indexed keywords

HEPARIN;

ARTICLE; CALCULATION; DIFFUSION; DRUG ADMINISTRATION; DRUG BINDING; DRUG DISTRIBUTION; PHARMACOKINETICS; PRIORITY JOURNAL; SIMULATION;

EID: 33750718235     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.1996.271.5.h2014     Document Type: Article

References (31)

1. Bratzler, R. L., C. K. Colton, and K. A. Smith. Endothelium and permeability: theoretical models for transport of low-density lipoproteins in the arterial wall. In: Atherosclerosis: Metabolic, Morphologic, and Clinical Aspects, edited by G. W. Manning and M. Daria-Haust. New York: Plenum, 1970, p. 943-951.
2. Burgess, W. H., and T. Maciag. The heparin binding (fibroblast) growth factor family of proteins. Am. Rev. Biochem. 58: 575-606, 1989.
3. Cardin, A. D., and H. J. R. Weintraub. Molecular modelling of protein-glycosaminoglycan interactions. Arteriosclerosis 9: 21-32, 1989.
4. Castellot, J. J. J., M. L. Addonizio, R. D. Rosenberg, and M. J. Karnovsky. Cultured endothelial cells produce a heparin-like inhibition of smooth muscle growth. J. Cell Biol. 90: 372-379, 1981.
5. Castellot, J. J. J., D. L. Cochran, and M. J. Karnovsky. Effect of heparin on vascular smooth muscle cells. I. Cell metabolism. J. Cell. Physiol. 124: 21-28, 1985.
6. Castellot, J. J. J., K. Wong, B. Herman, R. L. Hoover, D. F. Albertini, T. C. Wright, B. L. Caleb, and M. J. Karnovsky. Binding and internalization of heparin by vascular smooth muscle cells. J. Cell. Physiol. 124: 13-20, 1985.
7. Castellot, J. J. J., T. C. Wright, and M. J. Karnovsky. Regulation of vascular smooth muscle cell growth by heparin and heparan sulphate. Sem. Thromb. Hemost. 13: 489-503, 1987.
8. Edelman, E. R., D. A. Adams, and M. J. Karnovsky. Effect of controlled adventitial heparin delivery on smooth muscle cell proliferation following endothelial injury. Proc. Natl. Acad. Sci. USA 87: 3773-3777, 1990.
9. Edelman, E. R., and J. M. Karnovsky. Contrasting effects of the intermittent and continuous administration of heparin in experimental restenosis. Circulation 89: 770-776, 1994.
10. Ellis, S. G., G. S. Roubin, S. B. King, J. S. Douglas, W. S. Weintraub, R. G. Thomas, and W. R. Cox. Angiographic and clinical predictors of acute closure after native vessel coronary angioplasty. Circulation 77: 372-379, 1988.
11. Ellis, S. G., G. S. Roubin, J. Wilentz, J. Douglas, and S. King. Effect of 18- to 24-hour heparin administration for prevention of restenosis after uncomplicated coronary angioplasty. Am. Heart J. 117: 777-782, 1989.
12. Fry, D. L., and R. N. Vaishnav. Mass transport in the arterial wall. In: Basic Hemodynamics and Its Role in Disease Processes, edited by D. J. Patel and R. N. Vaishnav. Baltimore, MD: Univ. Park Press, 1980, p. 425-485.
13. Holman, J. P. Heat Transfer (6th ed.). New York: McGraw-Hill, 1963, p. 131-133.
14. Ip, J. H., V. Fuster, L. Badimon, J. Badimon, M. B. Taubman, and J. H. Chesebro. Syndromes of accelerated atherosclerosis: role of vascular injury and smooth muscle proliferation. J. Am. Coll. Cardiol. 15: 1667-1687, 1990.
15. Letourneur, D., B. L. Caleb, and J. J. J. Castellot. Heparin binding, internalization, and metabolism in vascular smooth muscle cells. II. Degradation and secretion in sensitive and resistant cells. J. Cell. Physiol. 165: 687-695, 1995.
16. Lincoff, A. M., E. J. Topol, and S. G. Ellis. Local drug delivery for the prevention of restenosis: fact, fancy and future. Circulation 90: 2070-2084, 1994.
17. Lovich, M., and E. Edelman. Mechanisms of transmural heparin transport in the rat abdominal aorta after local vascular delivery. Circ. Res. 77: 1143-1150, 1995.
18. Lovich, M. A., and E. R. Edelman. Tissue average binding and equilibrium distribution: an example with heparin in arterial tissues. Biophys. J. 70: 1553-1559, 1996.
19. March, K. L., S. Mohanraj, P. P. K. Ho, R. L. Wilensky, and D. R. Hathaway. Biodegradable microspheres containing a colchicine analogue inhibit DNA synthesis in vascular smooth muscle cells. Circulation 89: 1929-1933, 1994.
20. Nugent, M. A., and E. R. Edelman. Kinetics of basic fibroblast growth factor binding to its receptor and heparan sulfate proteoglycan: a mechanism for cooperativity. Biochemistry 31: 8876-8883, 1992.
21. Penn, M. S., G. M. Saidel, and G. M. Chisolm. Relative significance of endothelium and internal elastic lamina in regulating the entry of macromolecules into arteries in vivo. Circ. Res. 74: 74-82, 1994.
22. Riessen, R., and J. M. Isner. Prospects for site-specific delivery of pharmacologic and molecular therapies. J. Am. Coll. Cardiol. 23: 1234-1244, 1994.
23. Rogers, C., M. J. Karnovsky, and E. R. Edelman. Inhibition of experimental neointimal hyperplasia and thrombosis depends on the type of vascular injury and the site of drug administration. Circulation 88: 1215-1221, 1993.
24. Ruoslahti, E., and Y. Yamaguchi. Proteoglycans as modulators of growth factor activity. Cell 64: 867-869, 1991.
25. Saidel, G. M., E. D. Morris, and G. M. Chisolm. Transport of macromolecules in arterial wall in vivo: a mathematical model and analytical solutions. Adv. Exp. Med. Biol. 49: 153-169, 1987.
26. San Antonio, J. D., J. Slover, J. Lawler, M. J. Karnovsky, and A. D. Lander. Specificity in the interactions of extracellular matrix proteins with subpopulations of the glycosaminoglycan heparin. Biochemistry 32: 4746-4755, 1993.
27. Slepian, M. J., E. Weselcouch, P. Cambell, L. Roth, S. P. Massia, M. Kieras, and M. Philbrook. Endoluminal hydrogel polymer layers provide prolonged heparin delivery to porcine coronary artery wall in vivo. J. Am. Coll. Cardiol. 27, Suppl. A: 85A, 1996.
28. Truskey, G. A., C. K. Colton, and K. A. Smith. Quantitative analysis of protein transport in the arterial wall. In: Structure and Function of the Circulation, edited by C. J. Schwartz, N. T. Werthessen, and S. Wolf. New York: Plenum, 1981, p. 287-355.
29. Walford, G. D., M. M. Midei, T. R. Aversano, S. O. Gottlieb, P. H. Chew, C. O. Siu, K. P. Brin, and J. A. Brinker. Heparin after PTCA: increased early complications and no clinical benefit (Abstract). Circulation 84, Suppl. II: II-592, 1991.
30. Wolinsky, H. Local delivery: let's keep our eyes on the wall. J. Am. Coll. Cardiol. 24: 825-827, 1994.
31. Wolinsky, H., and S. N. Thung. Use of perforated balloon catheter to deliver concentrated heparin into the wall of the normal canine artery. J. Am. Coll. Cardiol. 15: 475-81, 1990.